BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

STU:BX2 (USA)  
€ 2.01 (-4.73%) May 13
At Loss
Market Cap:
€ 76.14M ($ 82.18M)
Enterprise V:
€ 101.99M ($ 110.08M)
Volume:
800.00
Avg Vol (2M):
2.97K
Also Trade In:

BioXcel Therapeutics Inc (STU:BX2) Stock News, Headlines & Updates

BioXcel Therapeutics Inc Stock News from GuruFocus

Total 61
  • 1
  • 2
May 09, 2024
Apr 25, 2024
Apr 22, 2024
Apr 10, 2024
Mar 13, 2024
Mar 03, 2024
BioXcel Therapeutics Inc Commercial Day Transcript
GuruFocus Research • 11:55pm
BioXcel Therapeutics Inc Commercial Day Transcript
GuruFocus Research • 11:55pm
Total 61
  • 1
  • 2
Show
Entries

Headlines

Total 0
  • 1
No recent news